Figure 1.
Inclusion of patients in main analyses. ∗The number of patients with a HRQoL evaluation at 2, 6, and 12 months is available in the supplemental Data. ∗∗The number of patients with a HRQoL evaluation prior to and post–allo-HSCT is available in the supplemental Data. allo-HSCT, allogeneic hematopoietic stem cell transplantation; HRQoL, health-related quality of life; N, number of patients.

Inclusion of patients in main analyses. ∗The number of patients with a HRQoL evaluation at 2, 6, and 12 months is available in the supplemental Data. ∗∗The number of patients with a HRQoL evaluation prior to and post–allo-HSCT is available in the supplemental Data. allo-HSCT, allogeneic hematopoietic stem cell transplantation; HRQoL, health-related quality of life; N, number of patients.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal